TrialThe New England journal of medicine2018
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Leora Horn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2,132 papers cite itlatest 60 shown
this paperpooled ittrialcites it